Skip to main content
Selvita S.A. logo

Selvita S.A. — Investor Relations & Filings

Ticker · SLV ISIN · PLSLVCR00029 LEI · 25940057WQ9YP5MOQF28 WAR Professional, scientific and technical activities
Open in API
Filings indexed 1,179 across all filing types
Latest filing 2026-05-28 Proxy Solicitation & In…
Country PL Poland
Listing WAR SLV

About Selvita S.A.

https://selvita.com/

Selvita S.A. is a preclinical contract research organization (CRO) providing integrated services for the pharmaceutical and biotechnology sectors. The company offers comprehensive solutions across the drug discovery and development continuum, from target validation to preclinical candidate nomination. Core drug discovery capabilities include medicinal chemistry, pharmacology, DMPK, and protein sciences, supporting a wide range of modalities such as small molecules, antibodies, and protein degraders. For drug development, Selvita provides analytical support for small and large molecules, formulation, microbiology services, and manufacturing for clinical trials. The company operates under GMP and GLP quality standards, offering flexible engagement models that range from standalone studies to fully integrated programs.

Recent filings

Filing Released Lang Actions
Formularz do głosowania
Proxy Solicitation & Information Statement Classification · 90% confidence The document contains the proxy voting form (‘Formularz do głosowania dla pełnomocnika’) and the full set of draft resolutions (“Uchwała nr 1–12”) for Selvita S.A.’s Ordinary General Meeting on June 24, 2026. It is clearly pre‐meeting material sent to shareholders to solicit their votes, rather than an AGM presentation, voting results, or the underlying financial reports. Thus it aligns with the Proxy Solicitation & Information Statement category.
2026-05-28 Polish
Projekty uchwał
AGM Information Classification · 90% confidence The document is a compilation of draft resolutions (Uchwały nr 1–18) to be considered and adopted at the Ordinary General Meeting (Zwyczajne Walne Zgromadzenie) of Selvita S.A. on 24 June 2026, including agenda approval, election of the chairman, approval of financial statements, profit allocation, and discharge (absolutorium). This is not the full annual report or financial statements themselves, but the materials/resolutions tabled at the AGM. Hence it falls under AGM Information (materials shared during the AGM).
2026-05-28 Polish
Ogłoszenie
Proxy Solicitation & Information Statement Classification · 87% confidence The document is a formal announcement (call) of the Ordinary General Meeting of shareholders, including the date, agenda, proposed statutory amendments, and detailed voting and participation procedures. It is part of the materials sent to shareholders to provide information about the meeting and solicit their votes. This aligns with the Proxy Solicitation & Information Statement category rather than a post‐meeting result or a financial report.
2026-05-28 Polish
Zwołanie Zwyczajnego Walnego Zgromadzenia Selvita S.A. / Convening of the Ordinary General Shareholders Meeting of Selvita S.A. - Content (PL)
Proxy Solicitation & Information Statement Classification · 90% confidence The document is in Polish and constitutes a formal notice convening the Annual General Meeting of Selvita S.A., including the agenda items for shareholder consideration and voting. It is a material sent to shareholders providing information on the upcoming meeting and soliciting their participation and votes. According to the filing definitions, this falls under Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to inform them and request votes at a meeting.
2026-05-28 Polish
Rozpoczęcie przeglądu opcji strategicznych / Commencement of a Strategic Options Review - Content (PL)
Regulatory Filings Classification · 75% confidence The text is a regulatory public announcement in Polish whereby Selvita S.A.’s board informs shareholders and the market of the launch of a strategic review process. It does not contain financial statements, dividends, M&A transaction specifics, nor propose an actual takeover bid or concrete financing measure. Rather, it is a general corporate disclosure about exploring options (including possible delisting, M&A, or financing). This falls under generic regulatory announcements that do not fit other categories, i.e., Regulatory Filings (RNS).
2026-05-21 Polish
Selvita_SA_sprawozdanie_finansowe_Q1
Interim / Quarterly Report Classification · 93% confidence The document is titled ‘Skrócone sprawozdanie finansowe Selvita S.A. za okres 01.01.2026 r. – 31.03.2026 r.’ and contains full condensed financial statements (balance sheet, income statement, cash flows, statement of changes, notes) for a single quarter. It is a comprehensive interim/quarterly report, not merely an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report. Q1 2026
2026-05-21 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.